Publication | Closed Access
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia
161
Citations
32
References
2011
Year
Hematological MalignancyTumor BiologyDual Mtorc1MedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaPharmacologyMtorc2 Inhibitor Azd8055Anti-cancer AgentOncologyRadiation OncologyCancer ResearchMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1